Heartflow HTFL
Heartflow, Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus
$59.10+2.21%close on Oct. 28, 2026 · volume 1.6M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 22, 2026 | Campbell Rogers Chief Medical Officer | Sold 10b5-1 plan | 23,933 | $55.01 | $1.32 million |
| Oct. 12, 2026 | John C.m. Farquhar Chief Executive Officer, director | Sold 10b5-1 plan | 38,900 | $49.57 | $1.93 million |
| Sept. 18, 2026 | Campbell Rogers Chief Medical Officer | Sold 10b5-1 plan | 19,682 | $50.15 | $987,052 |
| Sept. 18, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 16,766 | $50.75 | $850,926 |
| Sept. 17, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 7,579 | $50.11 | $379,816 |
| Sept. 15, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 668 | $50.01 | $33,408 |
| Sept. 14, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 4,593 | $50.24 | $230,744 |
| Sept. 11, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 29,714 | $50.06 | $1.49 million |
| Sept. 11, 2026 | John C.m. Farquhar Chief Executive Officer, director | Sold 10b5-1 plan | 3,890 | $50.00 | $194,500 |
| Sept. 10, 2026 | John C.m. Farquhar Chief Executive Officer, director | Sold 10b5-1 plan | 35,010 | $46.42 | $1.63 million |
| Sept. 8, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 6,640 | $50.03 | $332,212 |
| Sept. 3, 2026 | Vikram Verghese Chief Financial Officer | Sold 10b5-1 plan | 27,540 | $49.69 | $1.37 million |
Latest 12 of 18. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.